Trial of an app to support breast cancer survivors prescribed hormone therapy
- Conditions
- Breast cancerCancerMalignant neoplasm of breast
- Registration Number
- ISRCTN51581601
- Lead Sponsor
- King’s College London and Guy’s and St Thomas’ NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 2000
Phase one:
1. Diagnosed with primary breast cancer
2. Prescribed hormonal therapy within the last three years
Phase two:
1. =23 on the MARS
2. Has weekly access to smartphone or tablet
3. Has email address
1. Diagnosed with secondary or metastatic cancer
2. Prescribed duration of hormonal therapy is due to come to an end during trial
3. Current treatment for depression or psychiatric disorders
4. Not fluent in verbal and written English
Phase two:
1. Diagnosed with secondary or metastatic cancer
2. Prescribed duration of hormonal therapy is due to come to an end during trial
3. Current treatment for depression or psychiatric disorders
4. Not fluent in verbal and written English
5. Patient does not provide consent or refuses to be randomised
6. Patient is currently taking part in another trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method